Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patricia Gaule

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 16, 2023
Tissue Age Affects Antigenicity and Scoring for the 22C3 Immunohistochemistry Companion Diagnostic TestAileen I Fernandez, Patricia Gaule, David L Rimm
Journal of the National Cancer Institute|June 7, 2021
PD-L1 Expression Scoring: Noninterchangeable, Noninterpretable, Neither, or BothNiki Gavrielatou, Saba Shafi, Patricia Gaule, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 26, 2020
PD-L1 Protein Expression on Both Tumor Cells and Macrophages are Associated with Response to Neoadjuvant Durvalumab with Chemotherapy in Triple-negative Breast CancerFahad Shabbir Ahmed, Patricia Gaule, John McGuire, et al.
Cancer Research|June 29, 2021
Targeting Pyruvate Kinase M2 Phosphorylation Reverses Aggressive Cancer PhenotypesMaria Apostolidi, Ioannis A Vathiotis, Viswanathan Muthusamy, et al.
The Journal of Investigative Dermatology|February 21, 2025
PD-1H (VISTA) Expression in Cutaneous Squamous Cell Carcinoma Is Correlated with T-Cell Infiltration and ActivationMichal Kidacki, Christina Cho, Francesc Lopez-Giraldez, et al.
Breast Cancer Research : BCR|July 4, 2013
BreastMark: an integrated approach to mining publicly available transcriptomic datasets relating to breast cancer outcomeStephen F Madden, Colin Clarke, Patricia Gaule, et al.
Breast Cancer Research and Treatment|July 18, 2025
Quantitative assessment of HER2 expression in invasive ductal carcinoma and co-existing DCISHaiying Zhan, Nay Nwe Nyein Chan, Revekka Khaimova, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2017
B7-H3 Expression in NSCLC and Its Association with B7-H4, PD-L1 and Tumor-Infiltrating LymphocytesMehmet Altan, Vasiliki Pelekanou, Kurt A Schalper, et al.
The Journal of Investigative Dermatology|August 10, 2023
Immune Inhibitory Molecule PD-1 Homolog (VISTA) Colocalizes with CD11b Myeloid Cells in Melanoma and Is Associated with Poor OutcomesMatthew D Vesely, Michal Kidacki, Patricia Gaule, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2021
Multi-scale Pan-cancer Integrative Analyses Identify the STAT3-VSIR Axis as a Key Immunosuppressive Mechanism in Head and Neck CancerRamachandra Katabathula, Peronne Joseph, Salendra Singh, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 16, 2023
Tissue Age Affects Antigenicity and Scoring for the 22C3 Immunohistochemistry Companion Diagnostic TestAileen I Fernandez, Patricia Gaule, David L Rimm
Journal of the National Cancer Institute|June 7, 2021
PD-L1 Expression Scoring: Noninterchangeable, Noninterpretable, Neither, or BothNiki Gavrielatou, Saba Shafi, Patricia Gaule, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 26, 2020
PD-L1 Protein Expression on Both Tumor Cells and Macrophages are Associated with Response to Neoadjuvant Durvalumab with Chemotherapy in Triple-negative Breast CancerFahad Shabbir Ahmed, Patricia Gaule, John McGuire, et al.
Cancer Research|June 29, 2021
Targeting Pyruvate Kinase M2 Phosphorylation Reverses Aggressive Cancer PhenotypesMaria Apostolidi, Ioannis A Vathiotis, Viswanathan Muthusamy, et al.
The Journal of Investigative Dermatology|February 21, 2025
PD-1H (VISTA) Expression in Cutaneous Squamous Cell Carcinoma Is Correlated with T-Cell Infiltration and ActivationMichal Kidacki, Christina Cho, Francesc Lopez-Giraldez, et al.
Breast Cancer Research : BCR|July 4, 2013
BreastMark: an integrated approach to mining publicly available transcriptomic datasets relating to breast cancer outcomeStephen F Madden, Colin Clarke, Patricia Gaule, et al.
Breast Cancer Research and Treatment|July 18, 2025
Quantitative assessment of HER2 expression in invasive ductal carcinoma and co-existing DCISHaiying Zhan, Nay Nwe Nyein Chan, Revekka Khaimova, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2017
B7-H3 Expression in NSCLC and Its Association with B7-H4, PD-L1 and Tumor-Infiltrating LymphocytesMehmet Altan, Vasiliki Pelekanou, Kurt A Schalper, et al.
The Journal of Investigative Dermatology|August 10, 2023
Immune Inhibitory Molecule PD-1 Homolog (VISTA) Colocalizes with CD11b Myeloid Cells in Melanoma and Is Associated with Poor OutcomesMatthew D Vesely, Michal Kidacki, Patricia Gaule, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2021
Multi-scale Pan-cancer Integrative Analyses Identify the STAT3-VSIR Axis as a Key Immunosuppressive Mechanism in Head and Neck CancerRamachandra Katabathula, Peronne Joseph, Salendra Singh, et al.
Pageof 3